Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Treating hepatitis C at mild stage is cost effective

    • 13 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Grieve R, Roberts J, Wright M, Sweeting M, DeAngelis D, Rosenberg W, Bassendine M, Main J, Thomas H.Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C. Gut 55: 1332-1338, No. 9, Sep 2006

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Treating hepatitis C at mild stage is cost effective. Pharmacoecon. Outcomes News 515, 7 (2006). https://doi.org/10.2165/00151234-200605150-00020

    Download citation

    Keywords

    • Virus Infection
    • Markov Model
    • Sustained Virological Response
    • Antiviral Therapy
    • Virological Response